151 related articles for article (PubMed ID: 11598617)
41. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[TBL] [Abstract][Full Text] [Related]
42. [A clinical study of congenital adrenal hyperplasia].
Nanbu A; Kumamoto Y; Tachiki H; Itoh N; Mikuma N; Tsunekawa T; Takagi Y; Maruta H
Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
[TBL] [Abstract][Full Text] [Related]
43. Synthetic glucocorticoids instead of hydrocortisone do not increase mineralocorticoid needs in adult patients with salt wasting congenital adrenal hyperplasia.
Auer MK; Paizoni L; Nowotny H; Lottspeich C; Tschaidse L; Schmidt H; Bidlingmaier M; Reisch N
J Steroid Biochem Mol Biol; 2023 Jun; 230():106271. PubMed ID: 36764494
[TBL] [Abstract][Full Text] [Related]
44. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z; Benderly A; Kahana L; Zadik Z
J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
[TBL] [Abstract][Full Text] [Related]
45. Adrenal 21-hydroxylase deficiency in childhood: 25 years' experience.
Lim YJ; Batch JA; Warne GL
J Paediatr Child Health; 1995 Jun; 31(3):222-7. PubMed ID: 7669384
[TBL] [Abstract][Full Text] [Related]
46. Cortisol production rate. V. Congenital virilizing adrenal hyperplasia.
Migeon CJ; Kenny FM
J Pediatr; 1966 Nov; 69(5):779-86. PubMed ID: 4288888
[No Abstract] [Full Text] [Related]
47. [Diagnosis and therapy of growth disorders].
Swoboda W
Wien Med Wochenschr; 1973 Aug; 123(31):481-8. PubMed ID: 4783968
[No Abstract] [Full Text] [Related]
48. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
[TBL] [Abstract][Full Text] [Related]
49. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
50. Final height in congenital adrenal hyperplasia: the dilemma of hypercortisolism versus hyperandrogenism.
Cordeiro GV; Silva IN; Goulart EM; Chagas AJ; Kater CE
Arq Bras Endocrinol Metabol; 2013 Mar; 57(2):126-31. PubMed ID: 23525290
[TBL] [Abstract][Full Text] [Related]
51. Congenital adrenal hyperplasia.
Savage MO
Clin Endocrinol Metab; 1985 Nov; 14(4):893-909. PubMed ID: 3910306
[No Abstract] [Full Text] [Related]
52. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
Muirhead S; Sellers EA; Guyda H;
J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
[TBL] [Abstract][Full Text] [Related]
53. [Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)].
Himon F; Job JC; Pierson M; Canlorbe P
Ann Pediatr (Paris); 1981 Mar; 28(3):187-92. PubMed ID: 7224567
[No Abstract] [Full Text] [Related]
54. Adrenal corticosteroid replacement therapy.
Mortimer RH
Med J Aust; 1985 Oct; 143(8):350-2, 354. PubMed ID: 2995778
[No Abstract] [Full Text] [Related]
55. Is hydrocortisone really better?
Mathew J; Sudeep K
Indian J Pediatr; 2006 Jan; 73(1):107; author reply 107-8. PubMed ID: 16444079
[No Abstract] [Full Text] [Related]
56. Reversible cardiomyopathy caused by an uncommon form of congenital adrenal hyperplasia.
Al Jarallah AS
Pediatr Cardiol; 2004; 25(6):675-6. PubMed ID: 15136908
[TBL] [Abstract][Full Text] [Related]
57. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
58. Clinical review: Adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis.
Muthusamy K; Elamin MB; Smushkin G; Murad MH; Lampropulos JF; Elamin KB; Abu Elnour NO; Gallegos-Orozco JF; Fatourechi MM; Agrwal N; Lane MA; Albuquerque FN; Erwin PJ; Montori VM
J Clin Endocrinol Metab; 2010 Sep; 95(9):4161-72. PubMed ID: 20823467
[TBL] [Abstract][Full Text] [Related]
59. Congenital adrenal cortical hyperplasia--successful long-term treatment.
Panettiere F; Deller JJ; Escamilla RF
Calif Med; 1969 Nov; 111(5):359-61. PubMed ID: 5348036
[No Abstract] [Full Text] [Related]
60. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
David M; Sempé M; Blanc M; Nicolino M; Forest MG; Morel Y
Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
